Alternative Cutaneous Substitutes Based on Poly(l- co-d,l-lactic acid- co-trimethylene carbonate) with Schinus terebinthifolius Raddi Extract Designed for Skin Healing

Daniel Komatsu; Moema A Hausen; Ricardo Yugi Eri; Vinicius Leal; Flavia Pedrini; Camilo Yaksic; Thais F R Alves; Marco V Chaud; Camilla Fanelli; Irene Noronha; Eliana A R Duek

doi:10.1021/acsomega.9b02427

Alternative Cutaneous Substitutes Based on Poly(l- co-d,l-lactic acid- co-trimethylene carbonate) with Schinus terebinthifolius Raddi Extract Designed for Skin Healing

ACS Omega. 2019 Oct 23;4(19):18317-18326. doi: 10.1021/acsomega.9b02427. eCollection 2019 Nov 5.

Authors

Affiliations

¹ Biomaterials Laboratory, Medical and Health Sciences Faculty, Pontifical University Catholic of São Paulo (PUC-SP), Sorocaba 18060-030, SP, Brazil.
² Facultad de Ciencias de la Salud, Universidad Privada del Valle, Cochabamba, Bolivia.
³ Laboratory of Biomaterials and Nanotechnology, University of Sorocaba (UNISO), Sorocaba 18023-000, SP, Brazil.
⁴ Medical Faculty, University of São Paulo (USP), São Paulo 01246-903, SP, Brazil.

Abstract

The search for new therapies and drugs that act as topical agents to relieve pain and control the inflammatory processes in burns always attracted interest in clinical trials. As an alternative to synthetic drugs, natural extracts are useful in the development of new strategies and formulations for improving the quality of life. The aim of this study was to develop a wound dressing using poly(l-co-d,l-lactic acid-co-trimethylene carbonate) (PLDLA-TMC) containing Schinus terebinthifolius Raddi (S.T.R.). S.T.R. is a native Brazilian plant known for its strong anti-inflammatory responses. The membrane of PLDLA-TMC + S. terebinthifolius Raddi was prepared at different concentrations of S.T.R. (5, 10, 15, and 50%). The Fourier transform infrared results showed no change in the PLDLA-TMC spectrum after S.T.R. addition, whereas the swelling test showed changes only in PLDLA-TMC + S.T.R. at 50%. The wettability measurements showed a mass loss due to the decrease in the contact angle in all samples after the S.T.R. addition in the polymer, whereas the S.T.R. release test showed a linear delivery pattern. The scanning electron microscopy analysis showed that S.T.R. was homogeneously distributed at only 5 and 10%. Tensile tests demonstrated an increase in Young's modulus and a reduction in the elongation till rupture of PLDLA-TMC after the addition of S.T.R. The biocompatibility in vitro evaluation with rat fibroblast cells seeded in the membranes of PLDLA-TMC + S.T.R. showed that although S.T.R. interfered in cell morphology, all concentrations tested showed that cells were able to adhere and proliferate during 7 days. Thus, S.T.R. at 50% was chosen to be tested for in vivo trials. The histological and immunohistochemistry results revealed an accelerated skin healing at 7 days after controlled secondary burns were introduced in the dorsal skin, with a striking total recovery of the epidermis and high rates of molecular activation of cell proliferation. Due to the known biocompatibility properties of PLDLA-TMC and its stable release of S.T.R., we strongly recommend S.T.R.-containing PLDLA-TMC as a curative device to favor skin healing.